313 related articles for article (PubMed ID: 29433736)
1. The Role of FoxOs in Bone Health and Disease.
Kim HN; Iyer S; Ring R; Almeida M
Curr Top Dev Biol; 2018; 127():149-163. PubMed ID: 29433736
[TBL] [Abstract][Full Text] [Related]
2. Sirtuins and FoxOs in osteoporosis and osteoarthritis.
Almeida M; Porter RM
Bone; 2019 Apr; 121():284-292. PubMed ID: 30738214
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin1 Suppresses Osteoclastogenesis by Deacetylating FoxOs.
Kim HN; Han L; Iyer S; de Cabo R; Zhao H; O'Brien CA; Manolagas SC; Almeida M
Mol Endocrinol; 2015 Oct; 29(10):1498-509. PubMed ID: 26287518
[TBL] [Abstract][Full Text] [Related]
4. The Roles of FoxO Transcription Factors in Regulation of Bone Cells Function.
Ma X; Su P; Yin C; Lin X; Wang X; Gao Y; Patil S; War AR; Qadir A; Tian Y; Qian A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973091
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin1 (Sirt1) promotes cortical bone formation by preventing β-catenin sequestration by FoxO transcription factors in osteoblast progenitors.
Iyer S; Han L; Bartell SM; Kim HN; Gubrij I; de Cabo R; O'Brien CA; Manolagas SC; Almeida M
J Biol Chem; 2014 Aug; 289(35):24069-78. PubMed ID: 25002589
[TBL] [Abstract][Full Text] [Related]
6. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
Baum R; Gravallese EM
Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
[TBL] [Abstract][Full Text] [Related]
7. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
[TBL] [Abstract][Full Text] [Related]
8. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the role of FoxOs in bone--insights from mouse models.
Almeida M
Bone; 2011 Sep; 49(3):319-27. PubMed ID: 21664311
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in coupling of bone formation to resorption.
Martin T; Gooi JH; Sims NA
Crit Rev Eukaryot Gene Expr; 2009; 19(1):73-88. PubMed ID: 19191758
[TBL] [Abstract][Full Text] [Related]
12. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
15. c-Src-Dependent and -Independent Functions of Matk in Osteoclasts and Osteoblasts.
Kim JH; Kim K; Kim I; Seong S; Kim N
J Immunol; 2018 Apr; 200(7):2455-2463. PubMed ID: 29440352
[TBL] [Abstract][Full Text] [Related]
16. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption.
Sims NA
Int J Biochem Cell Biol; 2016 Oct; 79():14-23. PubMed ID: 27497989
[TBL] [Abstract][Full Text] [Related]
19. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
[TBL] [Abstract][Full Text] [Related]
20. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.
Ruiz P; Martin-Millan M; Gonzalez-Martin MC; Almeida M; González-Macias J; Ros MA
Sci Rep; 2016 Nov; 6():36201. PubMed ID: 27804995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
